GLP-1 receptor agonists have gained global attention for their weight-loss benefits. In India, the segment currently has two multinational players – Novo Nordisk and Eli Lilly.
Hot this week
Free News - Where voices unite, stories flourish, and community thrives through open dialogue and meaningful connections.
Get important news delivered directly to your inbox and stay connected!
